Seulki Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seulki Lee has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Xiaoyuan Chen
Center for Nuclear Medicine and Molecular Imaging (CNMMI) Shandong Cancer Hospital and Institute Jinan China
21 shared publications Jin Xie
14 shared publicationsMagdalena Swierczewska
Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York 11794, United States
14 shared publicationsLei Zhu
‡Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, Maryland 20892, United States
10 shared publicationsAshwinkumar Bhirde
‡Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, Maryland 20892, United States
7 shared publicationsFan Zhang
Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361005, China
7 shared publications
Latest Publications
- Open Access
- 14 November 2012
- Published by Wiley in Angewandte Chemie
- Vol. 124 (47) , 11830
Berichtigung: Tumor‐Homing Poly‐siRNA/Glycol Chitosan Self‐Cross‐Linked Nanoparticles for Systemic siRNA Delivery in Cancer Treatment
- 14 November 2012
- Published by Wiley in Angewandte Chemie
- Vol. 124 (47) , 11830
Open AccessBerichtigung: Tumor‐Homing Poly‐siRNA/Glycol Chitosan Self‐Cross‐Linked Nanoparticles for Systemic siRNA Delivery in Cancer Treatment
- Open Access
- 14 November 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (47) , 11661
Corrigendum: Tumor-Homing Poly-siRNA/Glycol Chitosan Self-Cross-Linked Nanoparticles for Systemic siRNA Delivery in Cancer Treatment
- 14 November 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (47) , 11661
Open AccessCorrigendum: Tumor-Homing Poly-siRNA/Glycol Chitosan Self-Cross-Linked Nanoparticles for Systemic siRNA Delivery in Cancer Treatment
- 1 October 2012
- Published by Elsevier in Journal of Controlled Release
- Vol. 163 (1) , 55-62
Real-time monitoring of caspase cascade activation in living cells
- 1 October 2012
- Published by Elsevier in Journal of Controlled Release
- Vol. 163 (1) , 55-62
Real-time monitoring of caspase cascade activation in living cells
- 13 June 2012
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 12 (7) , 3613-3620
A Facile, One-Step Nanocarbon Functionalization for Biomedical Applications
Despite their immense potential in biomedicine, carbon nanomaterials suffer from inefficient dispersion and biological activity in vivo. Here we utilize a single, yet multifunctional, hyaluronic acid-based biosurfactant to simultaneously disperse nanocarbons and target single-walled carbon nanotubes (SWCNTs) to CD44 receptor positive tumor cells with prompt uptake. Cellular uptake was monitored by intracellular enzyme-activated fluorescence, and localization of SWCNTs within cells was further confirmed by Raman mapping. In vivo photoacoustic, fluorescence, and positron emission tomography imaging of coated SWCNTs display high tumor targeting capability while providing long-term, fluorescence molecular imaging of targeted enzyme events. By utilizing a single biomaterial surfactant for SWCNT dispersion without additional bioconjugation, we designed a facile technique that brings nanocarbons closer to their biomedical potential.
- 13 June 2012
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 12 (7) , 3613-3620
A Facile, One-Step Nanocarbon Functionalization for Biomedical Applications
Despite their immense potential in biomedicine, carbon nanomaterials suffer from inefficient dispersion and biological activity in vivo. Here we utilize a single, yet multifunctional, hyaluronic acid-based biosurfactant to simultaneously disperse nanocarbons and target single-walled carbon nanotubes (SWCNTs) to CD44 receptor positive tumor cells with prompt uptake. Cellular uptake was monitored by intracellular enzyme-activated fluorescence, and localization of SWCNTs within cells was further confirmed by Raman mapping. In vivo photoacoustic, fluorescence, and positron emission tomography imaging of coated SWCNTs display high tumor targeting capability while providing long-term, fluorescence molecular imaging of targeted enzyme events. By utilizing a single biomaterial surfactant for SWCNT dispersion without additional bioconjugation, we designed a facile technique that brings nanocarbons closer to their biomedical potential.
- 2 January 2012
- Published by Wiley in Angewandte Chemie
- Vol. 124 (7) , 1657-1662
Multiplex Imaging of an Intracellular Proteolytic Cascade by using a Broad‐Spectrum Nanoquencher
- 2 January 2012
- Published by Wiley in Angewandte Chemie
- Vol. 124 (7) , 1657-1662
Multiplex Imaging of an Intracellular Proteolytic Cascade by using a Broad‐Spectrum Nanoquencher
- 2 January 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (7) , 1625-1630
Multiplex Imaging of an Intracellular Proteolytic Cascade by using a Broad‐Spectrum Nanoquencher
- 2 January 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (7) , 1625-1630
Multiplex Imaging of an Intracellular Proteolytic Cascade by using a Broad‐Spectrum Nanoquencher
- Open Access
- 1 January 2012
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (2) , 125-126
Protease Activity: Meeting Its Theranostic Potential
This themed issue provides up-to-date review and research articles covering the theranostic applications in the combined fields of protease research, diagnostics and drug development.
- 1 January 2012
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (2) , 125-126
Open AccessProtease Activity: Meeting Its Theranostic Potential
This themed issue provides up-to-date review and research articles covering the theranostic applications in the combined fields of protease research, diagnostics and drug development.
- Open Access
- 1 January 2012
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (2) , 156-179
Protease-Activated Drug Development
In this extensive review, we elucidate the importance of proteases and their role in drug development in various diseases with an emphasis on cancer. First, key proteases are introduced along with their function in disease progression. Next, we link these proteases as targets for the development of prodrugs and provide clinical examples of protease-activatable prodrugs. Finally, we provide significant design considerations needed for the development of the next generation protease-targeted and protease-activatable prodrugs.
- 1 January 2012
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (2) , 156-179
Open AccessProtease-Activated Drug Development
In this extensive review, we elucidate the importance of proteases and their role in drug development in various diseases with an emphasis on cancer. First, key proteases are introduced along with their function in disease progression. Next, we link these proteases as targets for the development of prodrugs and provide clinical examples of protease-activatable prodrugs. Finally, we provide significant design considerations needed for the development of the next generation protease-targeted and protease-activatable prodrugs.
- 20 December 2011
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 41 (7) , 2641-2655
High-sensitivity nanosensors for biomarker detection
High sensitivity nanosensors utilize optical, mechanical, electrical, and magnetic relaxation properties to push detection limits of biomarkers below previously possible concentrations. The unique properties of nanomaterials and nanotechnology are exploited to design biomarker diagnostics. High-sensitivity recognition is achieved by signal and target amplification along with thorough pre-processing of samples. In this tutorial review, we introduce the type of detection signals read by nanosensors to detect extremely small concentrations of biomarkers and provide distinctive examples of high-sensitivity sensors. The use of such high-sensitivity nanosensors can offer earlier detection of disease than currently available to patients and create significant improvements in clinical outcomes.
- 20 December 2011
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 41 (7) , 2641-2655
High-sensitivity nanosensors for biomarker detection
High sensitivity nanosensors utilize optical, mechanical, electrical, and magnetic relaxation properties to push detection limits of biomarkers below previously possible concentrations. The unique properties of nanomaterials and nanotechnology are exploited to design biomarker diagnostics. High-sensitivity recognition is achieved by signal and target amplification along with thorough pre-processing of samples. In this tutorial review, we introduce the type of detection signals read by nanosensors to detect extremely small concentrations of biomarkers and provide distinctive examples of high-sensitivity sensors. The use of such high-sensitivity nanosensors can offer earlier detection of disease than currently available to patients and create significant improvements in clinical outcomes.
- 1 December 2011
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 4 (2) , 330-342
Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives
Theranostics is a concept which refers to the integration of imaging and therapy. As an evolving new field, it is related to but different from traditional imaging and therapeutics. It embraces multiple techniques to arrive at a comprehensive diagnostic, in vivo molecular images and an individualized treatment regimen. More recently, there is a trend of tangling these efforts with emerging materials and nanotechnologies, in an attempt to develop novel platforms and methodologies to tackle practical issues in clinics. In this article, topics of rationally designed nanoparticles for the simultaneous imaging and therapy of cancer will be discussed. Several exemplary nanoparticle platforms such as polymeric nanoparticles, gold nanomaterials, carbon nanotubes, magnetic nanoparticles and silica nanoparticles will be elaborated on and future challenges of nanoparticle-based systems will be discussed.
- 1 December 2011
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 4 (2) , 330-342
Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives
Theranostics is a concept which refers to the integration of imaging and therapy. As an evolving new field, it is related to but different from traditional imaging and therapeutics. It embraces multiple techniques to arrive at a comprehensive diagnostic, in vivo molecular images and an individualized treatment regimen. More recently, there is a trend of tangling these efforts with emerging materials and nanotechnologies, in an attempt to develop novel platforms and methodologies to tackle practical issues in clinics. In this article, topics of rationally designed nanoparticles for the simultaneous imaging and therapy of cancer will be discussed. Several exemplary nanoparticle platforms such as polymeric nanoparticles, gold nanomaterials, carbon nanotubes, magnetic nanoparticles and silica nanoparticles will be elaborated on and future challenges of nanoparticle-based systems will be discussed.